CXCL9 and Alzheimer disease: Moreover, IFNγ-induced Th1-associated CXCR3 ligands CXCL9, CXCL10, and CXCL11 can be measured in AD patients (42–44) and are known to play a role in the chronic phase of AD (45, 46).